Genomma Lab Internacional... (GNMLF)

PNK: GNMLF · Real-Time Price · USD

1.24

0.00 (0.00%)

At close: Apr 30, 2025, 2:49 PM

Genomma Lab Internacional S.A.B. de C.V. Income Statement

Financials in MXN. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	4.41B	4.67B	5.09B	253.6M	253.27M	207.52M	252.04M	254.98M	231.64M	213.85M	215.72M	214.71M	201.9M	199.16M	192.93M	194.14M	173.39M
Cost of Revenue	1.64B	1.72B	1.82B	91.26M	87.95M	83.16M	94.73M	99.51M	89.51M	91.64M	82.51M	84.95M	75.52M	73.71M	74.04M	76.03M	66.82M
Gross Profit	2.77B	2.94B	3.27B	162.34M	165.31M	124.36M	157.31M	155.46M	142.13M	122.21M	133.21M	129.76M	126.39M	125.44M	118.88M	118.11M	106.57M
Operating Income	960.62M	1.01B	1.13B	162.34M	51.62M	43.6M	51.26M	47.84M	41.87M	45.35M	40.87M	41.63M	35.9M	40.26M	35.6M	37.32M	33.62M
Interest Income	28.25M	36.8M	25.35M	9.01M	34.96M	n/a	5.76M	3.67M	1.9M	1.85M	2.1M	1.51M	478.26K	1.93M	1.03M	56.3K	164.81K
Pretax Income	701.17M	599.15M	932.26M	45.94M	34.82M	4.33M	33.74M	33.73M	27.92M	24.43M	29.48M	31.84M	26.48M	31.43M	28M	26.66M	27.25M
Net Income	498.72M	473.49M	33.5M	34.43M	22.45M	-6.8M	21.27M	24.35M	19.85M	13M	19.8M	20.1M	17.06M	10.52M	19.04M	19.05M	15.61M
Selling & General & Admin	1.72B	1.84B	2.08B	109.08M	113.69M	80.76M	106.05M	107.62M	100.26M	76.86M	92.35M	88.13M	90.48M	85.18M	83.28M	80.79M	72.95M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	86.03M	87.11M	61.61M	-350.25K	1.8M	n/a	n/a	n/a	48.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1.81B	1.93B	2.14B	109.08M	113.69M	80.76M	106.05M	107.62M	100.26M	76.86M	92.35M	88.13M	90.48M	85.18M	83.28M	80.79M	72.95M
Interest Expense	220.1M	248.37M	230.25M	208.56M	200.62M	15.24M	17.73M	11.77M	11.4M	12.25M	12.94M	9.96M	11.69M	9.81M	12.46M	7.99M	7.62M
Selling & Marketing Expenses	n/a	n/a	n/a	72.8M	-1.69B	-1.42B	-1.69B	-1.69B	-1.64B	-1.57B	59.8M	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	3.45B	3.65B	3.96B	91.26M	201.65M	163.91M	200.78M	207.13M	189.77M	168.51M	174.85M	173.08M	166M	158.89M	157.33M	156.82M	139.77M
Income Tax Expense	202.45M	125.66M	272.2M	-34.43M	8.74M	10.95M	10.19M	9.19M	7.39M	14.42M	10.66M	10.37M	8.03M	14.45M	9.08M	8.41M	12.81M
Shares Outstanding (Basic)	973.79M	944.86M	944.93M	945.14M	945.14M	954.58M	954.58M	957.46M	961.99M	975.35M	998.19M	999.57M	1.01B	1B	1.01B	1.01B	1.01B
Shares Outstanding (Diluted)	973.79M	977.75M	944.93M	945.14M	945.14M	954.58M	954.58M	957.46M	961.99M	975.35M	998.19M	999.57M	1.01B	1B	1.01B	1.01B	1.01B
EPS (Basic)	0.51	0.48	0.04	0.04	0.02	-0.01	0.02	0.03	0.02	0.01	0.02	0.02	0.02	0.01	0.02	0.02	0.02
EPS (Diluted)	0.51	0.50	0.04	0.04	0.02	-0.01	0.02	0.03	0.02	0.01	0.02	0.02	0.02	0.01	0.02	0.02	0.02
EBITDA	1.02B	968.71M	1.25B	166.84M	57.05M	31.34M	54.72M	51.41M	43.13M	39.56M	45.29M	44.46M	38.73M	669.46M	37.41M	39.14M	35.54M
EBIT	921.27M	847.52M	1.16B	61.12M	48.59M	26.56M	51.48M	796.29M	39.32M	36.68M	42.42M	739.93M	38.17M	42.71M	753.38M	630.62M	34.87M
Depreciation & Amortization	97.02M	121.19M	88.53M	4.5M	5.43M	4.78M	3.46M	3.57M	3.81M	2.89M	2.87M	2.83M	2.82M	2.79M	1.81M	1.82M	1.92M